Protein Modification: Isoaspartic Acid

蛋白质修饰:异天冬氨酸

基本信息

  • 批准号:
    8652986
  • 负责人:
  • 金额:
    $ 29.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-06-01 至 2016-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our long-term goal is to better understand the etiologic roles of protein posttranslational modifications (PTMs). This project focuses on isoaspartic acid (isoAsp, isoD or beta-Asp), which is generated spontaneously from either asparagine deamidation or aspartic acid isomerization. IsoAsp has been found in myriad proteins (e.g., beta-amyloid in the brain and crystalline in the eyes). Notably, isoAsp imparts a D-configuration and beta-linkage into the peptide backbone; such alteration of peptide backbones is exceptionally rare and may drastically alter protein structure and function. While well-recognized in aging, its emerging roles in signaling, regulation and autoimmunity have yet been widely appreciated. A lack of comprehensive knowledge of isoAsp and the unique technical challenges in its analysis hamper progress in this field. For one thing, isoAsp formation is the smallest PTM by mass change (Da; isoAsp has the same mass as Asp). Recently, these technical barriers have been overcome by novel approaches that combine chemo-enzymatic labeling and enrichment with mass spectrometry. Four specific aims will be undertaken. First, proteomic analysis of isoAsp in samples with biochemical and medical relevance will be performed. Second, tight binders to isoAsp will be engineered and used as antibodies for applications that complement existing methodologies. Third, the substrate specificity of the repair enzyme protein isoaspartate methyltransferase (PIMT) will be probed, focusing most assiduously on poor substrates of PIMT. Isoaspartyl peptide library screening, enzyme kinetic characterization, proteomic analysis and protein structural modeling will be integrated to augur the fate of isoAsp in individual proteins and whole systems. Last, alternative metabolic pathways for isoAsp will be discovered. The proposed research will lead to the discovery of biomarkers of human diseases, and effective methods of prevention, intervention and treatment for age-related conditions, neurodegenerative disorders (e.g., Alzheimer's disease), autoimmune diseases and other isoAsp-related ailments.
描述(由申请人提供):我们的长期目标是更好地了解蛋白质翻译后修饰(PTM)的病因作用。该项目的重点是异天冬氨酸(isoAsp,isoD或β-Asp),它是由天冬酰胺脱酰胺或天冬氨酸异构化自发产生的。IsoAsp已在无数蛋白质中发现(例如,大脑中的β-淀粉样蛋白和眼睛中的晶体)。值得注意的是,isoAsp赋予肽骨架D-构型和β-连接;这种肽骨架的改变非常罕见,可能会彻底改变蛋白质的结构和功能。虽然在衰老中得到了广泛的认可,但其在信号传导、调节和自身免疫中的新兴作用尚未得到广泛的认识。缺乏对isoAsp的全面了解及其分析中的独特技术挑战阻碍了这一领域的进展。首先,isoAsp的形成 是质量变化的最小PTM(Da; isoAsp与Asp质量相同)。最近,这些技术障碍已被克服的新方法,结合联合收割机化学-酶标记和富集与质谱。将实现四个具体目标。首先,将对具有生物化学和医学相关性的样本中的isoAsp进行蛋白质组学分析。其次,将设计与isoAsp紧密结合的抗体,并将其用作补充现有方法的抗体。第三,底物特异性的修复酶蛋白质异天冬氨酸甲基转移酶(PIMT)将被探测,最刻苦地集中在穷人的PIMT基板。异天冬氨酸肽库筛选、酶动力学表征、蛋白质组学分析和蛋白质结构建模将被整合,以预测isoAsp在单个蛋白质和整个系统中的命运。最后,将发现isoAsp的替代代谢途径。拟议的研究将导致发现人类疾病的生物标志物,以及预防、干预和治疗与年龄有关的疾病、神经退行性疾病(例如,阿尔茨海默氏病),自身免疫性疾病和其他isoAsp-related疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ZHAOHUI SUNNY ZHOU其他文献

ZHAOHUI SUNNY ZHOU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ZHAOHUI SUNNY ZHOU', 18)}}的其他基金

Protein Modification: Isoaspartic Acid
蛋白质修饰:异天冬氨酸
  • 批准号:
    8473885
  • 财政年份:
    2012
  • 资助金额:
    $ 29.55万
  • 项目类别:
Protein Modification: Isoaspartic Acid
蛋白质修饰:异天冬氨酸
  • 批准号:
    8831697
  • 财政年份:
    2012
  • 资助金额:
    $ 29.55万
  • 项目类别:
Protein Modification: Isoaspartic Acid
蛋白质修饰:异天冬氨酸
  • 批准号:
    8275695
  • 财政年份:
    2012
  • 资助金额:
    $ 29.55万
  • 项目类别:
Mechanism and Inhibition for LuxS: A Biodefense Target
LuxS 的机制和抑制:生物防御目标
  • 批准号:
    7459634
  • 财政年份:
    2004
  • 资助金额:
    $ 29.55万
  • 项目类别:
Mechanism and Inhibition for LuxS: A Biodefense Target
LuxS 的机制和抑制:生物防御目标
  • 批准号:
    6719230
  • 财政年份:
    2004
  • 资助金额:
    $ 29.55万
  • 项目类别:
Mechanism and Inhibition for LuxS: A Biodefense Target
LuxS 的机制和抑制:生物防御目标
  • 批准号:
    7082899
  • 财政年份:
    2004
  • 资助金额:
    $ 29.55万
  • 项目类别:
Mechanism and Inhibition for LuxS: A Biodefense Target
LuxS 的机制和抑制:生物防御目标
  • 批准号:
    7254709
  • 财政年份:
    2004
  • 资助金额:
    $ 29.55万
  • 项目类别:
Mechanism and Inhibition for LuxS: A Biodefense Target
LuxS 的机制和抑制:生物防御目标
  • 批准号:
    6908135
  • 财政年份:
    2004
  • 资助金额:
    $ 29.55万
  • 项目类别:
Mechanism and Inhibition for LuxS: A Biodefense Target
LuxS 的机制和抑制:生物防御目标
  • 批准号:
    7390144
  • 财政年份:
    2004
  • 资助金额:
    $ 29.55万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 29.55万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 29.55万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 29.55万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 29.55万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 29.55万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 29.55万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 29.55万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 29.55万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 29.55万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 29.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了